Cigna Corp (CI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile
- GDPH17510D
- Pages: 27
- March 2017
- Total Views:1167
- Region : North America
- GlobalData
- Equity Research Report
Details
Cigna Corp (Cigna) is a global health service company that offers integrated plans and services such as medical, dental, disability, life and accident insurance and related products and services. The company offers these products to employers and organizations around the world to help them protect their workforce. It offers its products through its own sales offices in the domestic market and through distributors and licensors in foreign countries. The company, along with its subsidiaries, operates in the US, Canada, China, France, the Netherlands, Switzerland, the UAE, the UK, and Vietnam among others. Cigna is headquartered in Bloomfield, Connecticut, the US.
Cigna reported gross written premium of US$30,212 million during the fiscal year 2015 (FY2015), representing an increase of 8.6% over US$27,817 million in FY2014. Its total premiums earned were US$29,642 million in FY2015, an increase of 8.9% over US$27,214 million in FY2014.
Cigna Corp (CI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cigna Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cigna Corp, Medical Devices Deals, 2011 to YTD 2017 8
Cigna Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cigna Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cigna Enters into Contract with Novartis 10
Cigna And Samsung Electronics Enter Into Agreement To Provide Health Improvement Platform 10
Equity Offering 11
Cigna Completes Public Offering Of Common Stock For US$650 Million 11
HealthSpring Completes An Underwritten Public Offering For US$310 Million 13
Debt Offering 14
Cigna Completes Public Offering Of Notes Due 2016 For US$600 Million 14
Cigna Completes Public Offering Of Notes Due 2022 For US$750 Million 15
Cigna Completes Public Offering Of Notes Due 2042 For US$750 Million 17
Acquisition 18
Cigna Acquires Alegis Care, Healthcare Services Provider 18
CIGNA Completes Acquisition Of HealthSpring For US$3.8 Billion 19
Cigna Corp-Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List Of Figure
List of Figures
Cigna Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cigna Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cigna Corp, Medical Devices Deals, 2011 to YTD 2017 8
List Of Table
List of Tables
Cigna Corp, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cigna Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cigna Corp, Medical Devices Deals, 2011 to YTD 2017 8
Cigna Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cigna Enters into Contract with Novartis 10
Cigna And Samsung Electronics Enter Into Agreement To Provide Health Improvement Platform 10
Cigna Completes Public Offering Of Common Stock For US$650 Million 11
HealthSpring Completes An Underwritten Public Offering For US$310 Million 13
Cigna Completes Public Offering Of Notes Due 2016 For US$600 Million 14
Cigna Completes Public Offering Of Notes Due 2022 For US$750 Million 15
Cigna Completes Public Offering Of Notes Due 2042 For US$750 Million 17
Cigna Acquires Alegis Care, Healthcare Services Provider 18
CIGNA Completes Acquisition Of HealthSpring For US$3.8 Billion 19
Cigna Corp, Key Competitors 22
Cigna Corp, Key Employees 23
Cigna Corp, Other Locations 24
Cigna Corp, Subsidiaries 24
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Cigna Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Cigna Corp (Cigna) is a global health service company that offers integrated plans and services such as medical, dental, disability, life and accident insurance and related products and services. The company offers these products to employers and organizations around the world to help them protect their workforce. It offers its products through its own sales offices in the domestic market and through distributors and licensors in foreign countries. The company, along with its subsidiaries, operates in the US, Canada, China, France, the Netherlands, Switzerland, the UAE, the UK, and Vietnam among others. Cigna is headquartered in Bloomfield, Connecticut, the US.
Cigna reported gross written premium of US$30,212 million during the fiscal year 2015 (FY2015), representing an increase of 8.6% over US$27,817 million in FY2014. Its total premiums earned were US$29,642 million in FY2015, an increase of 8.9% over US$27,214 million in FY2014.
Cigna Corp (CI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cigna Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cigna Corp, Medical Devices Deals, 2011 to YTD 2017 8
Cigna Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cigna Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cigna Enters into Contract with Novartis 10
Cigna And Samsung Electronics Enter Into Agreement To Provide Health Improvement Platform 10
Equity Offering 11
Cigna Completes Public Offering Of Common Stock For US$650 Million 11
HealthSpring Completes An Underwritten Public Offering For US$310 Million 13
Debt Offering 14
Cigna Completes Public Offering Of Notes Due 2016 For US$600 Million 14
Cigna Completes Public Offering Of Notes Due 2022 For US$750 Million 15
Cigna Completes Public Offering Of Notes Due 2042 For US$750 Million 17
Acquisition 18
Cigna Acquires Alegis Care, Healthcare Services Provider 18
CIGNA Completes Acquisition Of HealthSpring For US$3.8 Billion 19
Cigna Corp-Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List Of Figure
List of Figures
Cigna Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cigna Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cigna Corp, Medical Devices Deals, 2011 to YTD 2017 8
List Of Table
List of Tables
Cigna Corp, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 1
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cigna Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cigna Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cigna Corp, Medical Devices Deals, 2011 to YTD 2017 8
Cigna Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cigna Enters into Contract with Novartis 10
Cigna And Samsung Electronics Enter Into Agreement To Provide Health Improvement Platform 10
Cigna Completes Public Offering Of Common Stock For US$650 Million 11
HealthSpring Completes An Underwritten Public Offering For US$310 Million 13
Cigna Completes Public Offering Of Notes Due 2016 For US$600 Million 14
Cigna Completes Public Offering Of Notes Due 2022 For US$750 Million 15
Cigna Completes Public Offering Of Notes Due 2042 For US$750 Million 17
Cigna Acquires Alegis Care, Healthcare Services Provider 18
CIGNA Completes Acquisition Of HealthSpring For US$3.8 Billion 19
Cigna Corp, Key Competitors 22
Cigna Corp, Key Employees 23
Cigna Corp, Other Locations 24
Cigna Corp, Subsidiaries 24
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Cigna Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020